Toxicogenomics - A new paradigm of toxicology and birth of reverse toxicology

Bulletin of National Institute of Health Sciences

Volumn , Issue 120, 2002, Pages 39-52

  Hirabayashi, Yoko ^a   Inoue, Tohru ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

DNA chip; Microarray; Proteomics; Reverse toxicology; Toxicogenomics

Indexed keywords

BIOLOGICAL MARKER;

DNA MICROARRAY; EXPERIMENTAL ANIMAL; GENE EXPRESSION; GENOME; PHARMACOGENOMICS; PROTEOMICS; REVIEW; TOXICOGENOMICS; TOXICOLOGY; BIOLOGY; HUMAN; METHODOLOGY; PHARMACOGENETICS;

COMPUTATIONAL BIOLOGY; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; PROTEOMICS; TOXICOLOGY;

EID: 0036447274     PISSN: 13434292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Tennant, R. W.: The National Center for Toxicogenomics: Using new technologies to inform mechanistic toxicology. Environ Health Perspect, 110: A8-10. (2002)
2. "Toxicology for the Next Millennium." Proceedings of a conference. September 20-23, 1999, Warrenton, Virginia, USA. eds. by, Isfort, R.J. and Lederberg, J., Annals of the New York Acad Sci, 919, New York, pp. 1-324. (2000)
3. Brown, P. O. and Botstein, D.: Exploring the new world of the genome with DNA microarrays. Nat Genet, 21: 33-7. (1999)
4. Debouck, C. and Goodfellow, P. N.: DNA microarrays in drug discovery and development. Nat Genet, 21: 48-50. (1999)
5. Lovett, R. A.: Toxicogenomics. Toxicologists brace for genomics revolution. Science, 289: 536-7. (2000)
6. Hamadeh, H. K., Bushel, P., Paules, R. and Afshari, C. A.: Discovery in toxicology: Mediation by gene expression array technology. J Biochem Mol Toxicol, 15: 231-42. (2001)
7. Storck, T., von Brevern, M. C., Behrens, C. K., Scheel, J. and Bach, A.: Transcriptomics in predictive toxicology. Curr Opin Drug Discov Devel, 5: 90-7. (2002)
8. Schena, M., Shalon, D., Davis, R. W. and Brown, P. O.: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 270: 467-70. (1995)
9. Schena, M., Shalon, D., Heller, R., Chai, A., Brown, P. O. and Davis, R. W.: Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA, 93: 10614-9. (1996)
10. Fodor, S. P., Rava, R. P., Huang, X. C., Pease, A. C., Holmes, C. P. and Adams, C. L.: Multiplexed biochemical assays with biological chips. Nature, 364: 555-6. (1993)
11. Adam, G. I.: The development of pharmacogenomic models to predict drug response. Curr Opin Drug Discov Devel, 4: 296-300. (2001)
12. Lloyd, A.: Pharmacogenomics: Qualitative gene profiling using differential analysis of transcripts with alternative splicing. Drug Discov Today, 5: 429-430. (2000)
13. McCarthy, J. J. and Hilfiker, R.: The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol, 18: 505-8. (2000)
14. Liefers, G. J., Tollenaar, R. A., Nakamura, Y. and van de Velde, C. J.: Genetic cancer syndromes and large-scale gene expression analysis: Applications in surgical oncology. Eur J Surg Oncol, 27: 343-8. (2001)
15. Gabrielson, E., Berg, K. and Anbazhagan, R.: Functional genomics, gene arrays, and the future of pathology. Mod Pathol, 14: 1294-9. (2001)
16. Kallioniemi, O. P., Wagner, U., Kononen, J. and Sauter, G.: Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet, 10: 657-62. (2001)
17. Aardema, M. J. and MacGregor, J. T.: Toxicology and genetic toxicology in the new era of "toxicogenomics": Impact of "-omics" technologies. Mutat Res, 499: 13-25. (2002)
18. Gollapudi, B. B. and Krishna, G.: Practical aspects of mutagenicity testing strategy: An industrial perspective. Mutat Res, 455: 21-8. (2000)
19. Herrmann, J. L., Rastelli, L., Burgess, C. E., Fernandez, E. E., Rothberg, B. E., Rothberg, J. M. and Shimkets, R. A.: Implications of oncogenomics for cancer research and clinical oncology. Cancer J, 7: 40-51. (2001)
20. Nakamura, Y.: Isolation of disease-associated genes through genome analysis and their clinical application. Keio J Med, 50: 134-40. (2001)
21. Torhorst, J., Bucher, C., Kononen, J., Haas, P., Zuber, M., Kochli, O. R., Mross, F., Dieterich, H., Moch, H., Mihatsch, M., Kallioniemi, O. P. and Sauter, G.: Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol, 159: 2249-56. (2001)
22. Reynolds, L. J. and Richards, R. J.: Can toxicogenomics provide information on the bioreactivity of diesel exhaust particles? Toxicology, 165: 145-52, (2001)
23. rd Ed., eds. by, Wexler, P., Hakkinen, P.J., Kennedy, G., Stoss, F.W., Academic Press, San Diego, pp.921 (1999)
24. Inoue, M., Sakaguchi, N., Isuzugawa, K., Tani, H. and Ogihara, Y.: Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull, 23: 1153-7. (2000)
25. Hetts, S. W.: To die or not to die: An overview of apoptosis and its role in disease. Jama, 279: 300-7. (1998)
26. Smith, L. L.: Key challenges for toxicologists in the 21st century. Trends Pharmacol Sci, 22: 281-5. (2001)
27. Fielden, M. R. and Zacharewski, T. R.: Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicol Sci, 60: 6-10. (2001)
28. Pennie, W. D., Woodyatt, N. J., Aldridge, T. C. and Orphanides, G.: Application of genomics to the definition of the molecular basis for toxicity. Toxicol Lett, 120: 353-8. (2001)
29. Nuwaysir, E. F., Bittner, M., Trent, J., Barrett, J. C. and Afshari, C. A.: Microarrays and toxicology: The advent of toxicogenomics. Mol Carcinog, 24: 153-9. (1999)
30. Hamadeh, H. K., Bushel, P. R., Jayadev, S., Martin, K., DiSorbo, O., Sieber, S., Bennett, L., Tennant, R., Stoll, R., Barrett, J. C., Blanchard, K., Paules, R. S. and Afshari, C. A.: Gene expression analysis reveals chemical-specific profiles. Toxicol Sci, 67: 219-31. (2002) Hamadeh, H. K., Bushel, P.R., Jayadev, S., DiSorbo, O., Hamadeh, H. K., Bushel, P. R., Jayadev, S., DiSorbo, O., Bennett L., Li, L., Tennant, R., Stoll, R., Barrett, J.C., Bennett, L., Li, L., Tennant, R., Stoll, R., Barrett, J. C., Paules, R. S., Blanchard, K., Afshari, C. A.: Prediction of compound signature using high density gene expression profiling Toxicol Sci, 67: 232-40. (2000)
31. Hamadeh, H. K., Bushel, P. R., Jayadev, S., Martin, K., DiSorbo, O., Sieber, S., Bennett, L., Tennant, R., Stoll, R., Barrett, J. C., Blanchard, K., Paules, R. S. and Afshari, C. A.: Gene expression analysis reveals chemical-specific profiles. Toxicol Sci, 67: 219-31. (2002) Hamadeh, H. K., Bushel, P.R., Jayadev, S., DiSorbo, O., Hamadeh, H. K., Bushel, P. R., Jayadev, S., DiSorbo, O., Bennett L., Li, L., Tennant, R., Stoll, R., Barrett, J.C., Bennett, L., Li, L., Tennant, R., Stoll, R., Barrett, J. C., Paules, R. S., Blanchard, K., Afshari, C. A.: Prediction of compound signature using high density gene expression profiling Toxicol Sci, 67: 232-40. (2000)
32. Olden, K., Guthrie, J. and Newton, S.: A bold new direction for environmental health research. Am J Public Health, 91: 1964-7. (2001)
33. Schwartzberg, P. L., Goff S. P. and Robertson, E. J.: Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science, 246: 799-803. (1989)
34. Capecchi, M. R.: Altering the genome by homologous recombination. Science, 244: 1288-92. (1989)
35. Stanton, B. R., Reid, S. W. and Parada, L. F.: Germ line transmission of an inactive N-myc allele generated by homologous recombination in mouse embryonic stem cells. Mol Cell Biol, 10: 6755-8. (1990)
36. te Riele, H., Maandag, E. R., Clarke, A., Hooper, M. and Berns, A.: Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature, 348: 649-51. (1990)
37. Yagi, T., Ikawa, Y., Yoshida, K., Shigetani, Y., Takeda, N., Mabuchi, I., Yamamoto, T. and Aizawa, S.: Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc Natl Acad Sci USA, 87: 9918-22. (1990)
38. Zijlstra, M., Li, E., Sajjadi, F., Subramani, S. and Jaenisch, R.: Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature, 342: 435-8. (1989)
39. Copeland, N. G., Jenkins, N. A. and Court, D. L.: Recombineering: A powerful new tool for mouse functional genomics. Nat Rev Genet, 2: 769-79. (2001)
40. Saga, Y., Hata, N., Kobayashi, S., Magnuson, T., Seldin, M. F. and Taketo, M. M.: MesP1: A novel basic helix-loop-helix protein expressed in the nascent mesodermal cells during mouse gastrulation. Development, 122: 2769-78. (1996)
41. Yoon, B. I., Hirabayashi, Y., Kawasaki, Y., Kodama, Y., Kaneko, T., Kim, D. Y. and Inoue, T.: Mechanism of action of benzene toxicity: Cell cycle suppression in hemopoietic progenitor cells (CFU-GM). Exp Hematol, 29: 278-85. (2001)
42. Snyder, C. A., Goldstein, B. D., Sellakumar, A. R., Bromberg, I., Laskin, S. and Albert, R. E.: The inhalation toxicology of benzene: Incidence of hematopoietic neoplasms and hematotoxicity in ARK/J and C57BL/6J mice. Toxicol Appl Pharmacol, 54: 323-31. (1980)
43. Cronkite, E. P., Bullis, J., Inoue, T. and Drew, R. T.: Benzene inhalation produces leukemia in mice. Toxicol Appl Pharmacol, 75: 358-61. (1984)
44. Le Noir, and Claude: Sur un cas de purpura attribué a l'intoxication par la benzine, Séance du, 29, 1251-60. (1887)
45. Kawasaki, Y., Hirabayashi, Y., Yoon, B.I., Huo, Y., Kaneko, T., Kyrokawa, Y., Inoue, T.: Benzene inhalation induced an early onset and a high incidence of leukemias in the p53 deficient C57BL/6 mice. Japanese Journal of Cancer Research, 92 suppl.: 71. (2001)
46. Yoon, B.I., Hirabayashi, Y., Kawasaki, Y., Kodama, Y., Igarashi, K., Kanno, J., Kaneko, T., Inoue, T.: cDNA microarray in mouse bone marrow cells: Profiles reflecting the epigenetic responses to benzene. Meeting abstract of the 23rd Annual meeting of the Molecular Biology Society of Japan, 669. (2000)
47. Berger, M., Fagioli, F., Piacibello, W., Sanavio, F., Mareschi, K., Biasin, E., Bruno, S., Gammaitoni, L., Gunetti, M., Nesi, F., Madon, E. and Aglietta, M.: Role of different medium and growth factors on placental blood stem cell expansion: An in vitro and in vivo study. Bone Marrow Transplant, 29: 443-8. (2002)
48. Batard, P., Monier, M. N., Fortunel, N., Ducos, K., Sansilvestri-Morel, P., Phan, T., Hatzfeld, A. and Hatzfeld, J. A.: TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci, 113: 383-90. (2000)
49. Pincus, D. W., Keyoung, H. M., Harrison-Restelli, C., Goodman, R. R., Fraser, R. A., Edgar, M., Sakakibara, S., Okano, H., Nedergaard, M. and Goldman, S. A.: Fibroblast growth factor-2/brain-derived neurotrophic factor-associated maturation of new neurons generated from adult human subependymal cells. Ann Neurol, 43: 576-85. (1998)
50. Naciff, J. M., Jump, M. L., Torontali, S. M., Garr, G. J., Tiesman, J. P., Overmann, G. J. and Daston, G. P.: Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol a, and genistein in the developing female reproductive system of the rat. Toxicol Sci, 68: 184-99. (2002)
51. Schreyer, S. K., Karkanitsa, L. V., Albanese, J., Ostapenko, V. A., Shevchuk, V. Y., and Dainiak, N.: Analysis of radiation-associated changes in gene expression using microarray technology. In: Proceedings of the Advanced Research Workshop on Protracted Intermittent or Chronic Irradiation: Biological Effect and Mechanisms of Tolerance, 14-17 May 2002, Schloss Reisenburg, Germany (in press).